-
EP1339685
European procedure
Extract from the Register of European Patents
EP About this file: EP1339685
| EP1339685 - BIPHENYLCARBOXAMIDES USEFUL AS LIPID LOWERING AGENTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 07.09.2007 Database last updated on 02.09.2024 | Most recent event Tooltip | 14.10.2011 | Lapse of the patent in a contracting state New state(s): PT | published on 16.11.2011 [2011/46] | Applicant(s) | For all designated states Janssen Pharmaceutica NV Patent Department Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
| Former [2006/44] | For all designated states JANSSEN PHARMACEUTICA N.V. Patent Department Turnhoutseweg 30 2340 Beerse / BE | ||
| Former [2003/36] | For all designated states JANSSEN PHARMACEUTICA N.V. Patent Department Turnhoutsebaan 30 2340 Beerse / BE | Inventor(s) | 01 /
MEERPOEL, Lieven, Janssen Pharmaceutica N.V. Turnhoutseweg 30 B-2340 Beerse / BE | 02 /
BACKX, Leo, Jacobus Jozef, Janssen Pharma. N.V. Turnhoutseweg 30 B-2340 Beerse / BE | [2003/36] | Application number, filing date | 01997477.3 | 15.11.2001 | [2003/36] | WO2001EP13316 | Priority number, date | EP20000204150 | 21.11.2000 Original published format: EP 00204150 | [2003/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0242271 | Date: | 30.05.2002 | Language: | EN | [2002/22] | Type: | A2 Application without search report | No.: | EP1339685 | Date: | 03.09.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.05.2002 takes the place of the publication of the European patent application. | [2003/36] | Type: | B1 Patent specification | No.: | EP1339685 | Date: | 02.11.2006 | Language: | EN | [2006/44] | Search report(s) | International search report - published on: | EP | 21.11.2002 | Classification | IPC: | C07D211/58, C07D207/14, C07C233/80, A61K31/40, A61K31/402, A61K31/445, A61K31/216, A61P3/06, A61P3/10 | [2003/36] | CPC: |
C07C237/20 (EP,US);
C07D211/58 (EP,KR,US);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
C07C233/80 (EP,US);
C07D207/14 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/36] | Extension states | AL | 23.06.2003 | LT | 23.06.2003 | LV | 23.06.2003 | MK | 23.06.2003 | RO | 23.06.2003 | SI | 23.06.2003 | Title | German: | BIPHENYLCARBONSÄUREAMIDE, DIE SICH ALS LIPIDSENKER EIGNEN | [2003/36] | English: | BIPHENYLCARBOXAMIDES USEFUL AS LIPID LOWERING AGENTS | [2003/36] | French: | BIPHENYLCARBOXAMIDES UTILES COMME HYPOLIPIDEMIANTS | [2003/36] | Entry into regional phase | 23.06.2003 | National basic fee paid | 23.06.2003 | Designation fee(s) paid | 23.06.2003 | Examination fee paid | Examination procedure | 29.04.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 23.06.2003 | Examination requested [2003/36] | 05.08.2005 | Despatch of a communication from the examining division (Time limit: M04) | 24.11.2005 | Reply to a communication from the examining division | 08.05.2006 | Communication of intention to grant the patent | 18.09.2006 | Fee for grant paid | 18.09.2006 | Fee for publishing/printing paid | Opposition(s) | 03.08.2007 | No opposition filed within time limit [2007/41] | Fees paid | Renewal fee | 01.12.2003 | Renewal fee patent year 03 | 30.11.2004 | Renewal fee patent year 04 | 30.11.2005 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | PT | 02.11.2006 | TR | 02.11.2006 | MC | 30.11.2006 | GR | 03.02.2007 | [2011/46] |
| Former [2009/42] | TR | 02.11.2006 | |
| MC | 30.11.2006 | ||
| GR | 03.02.2007 | ||
| Former [2008/48] | MC | 30.11.2006 | |
| GR | 03.02.2007 | ||
| Former [2007/37] | MC | 30.11.2006 | Cited in | International search | [YD]EP0643057 (BRISTOL MYERS SQUIBB CO [US]) [YD] 1-9 * example 206 ** claims 19-21 *; | [Y]WO9823593 (PFIZER [US], et al) [Y] 1-9 * claim 43 * * examples 31,49,68-72,77,80-84,108-110 *; | [Y]WO0032582 (GLAXO GROUP LTD [GB], et al) [Y] 1-9 * example 76 * * page 19, line 5 - line 16 *; | [PX]WO0177077 (NOVARTIS AG [CH], et al) [PX] 1-10 * page 57; example F * * page 58; example K * * page 59; example L * * page 60; examples P,S * * page 62; examples AA,X * * examples 6,8 * * claims 12,13 *; | [EL]WO0220501 (JANSSEN PHARMACEUTICA NV [BE], et al) [EL] 1-10 * page 87; examples 251,252 * * claims 17,18 * * L:Priority * |